KLS Martin Reports Record €518 Million Revenue in 2025, Plans Major Investments for 2026

German medical technology company KLS Martin achieved a record group revenue of €518 million in 2025, marking a 6% increase compared to the previous year despite challenging global economic conditions. This growth could have been even stronger, with currency-adjusted figures suggesting a 10% rise, according to statements from Managing Partner Christian Leibinger. The company, which employs over 2,700 people worldwide, saw particularly strong demand in the oral, maxillofacial, and hand surgery as well as traumatology sectors.

The United States remains a primary growth driver for KLS Martin, while traditionally saturated European markets such as Germany, the UK, Italy, and Spain also contributed positively to revenue increases.

Looking ahead to 2026, KLS Martin plans significant investments concentrated on infrastructure and technology enhancements, with a targeted investment volume in the triple-digit million euro range. Notably, the company is initiating construction for a new research and development center with an integrated cafeteria planned for approximately 220 employees. Additional projects include a new employee and visitor parking facility and a new logistics center in Tuttlingen, reinforcing the company's commitment to its German sites.

Leibinger emphasized that the firm’s strong financial performance ``reflects our commitment to innovation,'' highlighting the firm’s ongoing modernization and digitalization efforts. These strategic initiatives aim to bolster production capabilities and maintain KLS Martin’s competitive positioning despite the economic uncertainties facing the global market.

KLS Martin’s sustained revenue growth and ambitious investment plans demonstrate resilience and strategic confidence as it expands its footprint both domestically and internationally, positioning itself for continued success in medical technology innovation and market expansion.